124 related articles for article (PubMed ID: 31265136)
21. A joint transcriptome-wide association study across multiple tissues identifies candidate breast cancer susceptibility genes.
Gao G; Fiorica PN; McClellan J; Barbeira AN; Li JL; Olopade OI; Im HK; Huo D
Am J Hum Genet; 2023 Jun; 110(6):950-962. PubMed ID: 37164006
[TBL] [Abstract][Full Text] [Related]
22. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer.
Zhao H; Shen J; Medico L; Wang D; Ambrosone CB; Liu S
PLoS One; 2010 Oct; 5(10):e13735. PubMed ID: 21060830
[TBL] [Abstract][Full Text] [Related]
23. Plasma proteomic associations with genetics and health in the UK Biobank.
Sun BB; Chiou J; Traylor M; Benner C; Hsu YH; Richardson TG; Surendran P; Mahajan A; Robins C; Vasquez-Grinnell SG; Hou L; Kvikstad EM; Burren OS; Davitte J; Ferber KL; Gillies CE; Hedman ÅK; Hu S; Lin T; Mikkilineni R; Pendergrass RK; Pickering C; Prins B; Baird D; Chen CY; Ward LD; Deaton AM; Welsh S; Willis CM; Lehner N; Arnold M; Wörheide MA; Suhre K; Kastenmüller G; Sethi A; Cule M; Raj A; ; ; ; ; ; ; ; ; ; Burkitt-Gray L; Melamud E; Black MH; Fauman EB; Howson JMM; Kang HM; McCarthy MI; Nioi P; Petrovski S; Scott RA; Smith EN; Szalma S; Waterworth DM; Mitnaul LJ; Szustakowski JD; Gibson BW; Miller MR; Whelan CD
Nature; 2023 Oct; 622(7982):329-338. PubMed ID: 37794186
[TBL] [Abstract][Full Text] [Related]
24. The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors.
Quigley DA; Fiorito E; Nord S; Van Loo P; Alnæs GG; Fleischer T; Tost J; Moen Vollan HK; Tramm T; Overgaard J; Bukholm IR; Hurtado A; Balmain A; Børresen-Dale AL; Kristensen V
Mol Oncol; 2014 Mar; 8(2):273-84. PubMed ID: 24388359
[TBL] [Abstract][Full Text] [Related]
25. Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.
Cabezón T; Gromova I; Gromov P; Serizawa R; Timmermans Wielenga V; Kroman N; Celis JE; Moreira JM
Mol Cell Proteomics; 2013 Feb; 12(2):381-94. PubMed ID: 23172894
[TBL] [Abstract][Full Text] [Related]
26. Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER consortium.
Yao S; Haddad SA; Hu Q; Liu S; Lunetta KL; Ruiz-Narvaez EA; Hong CC; Zhu Q; Sucheston-Campbell L; Cheng TY; Bensen JT; Johnson CS; Trump DL; Haiman CA; Olshan AF; Palmer JR; Ambrosone CB
Int J Cancer; 2016 May; 138(9):2118-26. PubMed ID: 26650177
[TBL] [Abstract][Full Text] [Related]
27. Integrating genomics and proteomics data to identify candidate plasma biomarkers for lung cancer risk among European descendants.
Yang Y; Xu S; Jia G; Yuan F; Ping J; Guo X; Tao R; Shu XO; Zheng W; Long J; Cai Q
Br J Cancer; 2023 Oct; 129(9):1510-1515. PubMed ID: 37679517
[TBL] [Abstract][Full Text] [Related]
28. Associations of two common genetic variants with breast cancer risk in a chinese population: a stratified interaction analysis.
Lin Y; Fu F; Chen M; Huang M; Wang C
PLoS One; 2014; 9(12):e115707. PubMed ID: 25531440
[TBL] [Abstract][Full Text] [Related]
29. Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer.
Gao G; Pierce BL; Olopade OI; Im HK; Huo D
PLoS Genet; 2017 Sep; 13(9):e1006727. PubMed ID: 28957356
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review.
Fletcher O; Gibson L; Johnson N; Altmann DR; Holly JM; Ashworth A; Peto J; Silva Idos S
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):2-19. PubMed ID: 15668470
[TBL] [Abstract][Full Text] [Related]
31. Association between circulating vitamin E and ten common cancers: evidence from large-scale Mendelian randomization analysis and a longitudinal cohort study.
Xin J; Jiang X; Ben S; Yuan Q; Su L; Zhang Z; Christiani DC; Du M; Wang M
BMC Med; 2022 May; 20(1):168. PubMed ID: 35538486
[TBL] [Abstract][Full Text] [Related]
32. Identification of Novel Susceptibility Loci and Genes for Prostate Cancer Risk: A Transcriptome-Wide Association Study in Over 140,000 European Descendants.
Wu L; Wang J; Cai Q; Cavazos TB; Emami NC; Long J; Shu XO; Lu Y; Guo X; Bauer JA; Pasaniuc B; Penney KL; Freedman ML; Kote-Jarai Z; Witte JS; Haiman CA; Eeles RA; Zheng W;
Cancer Res; 2019 Jul; 79(13):3192-3204. PubMed ID: 31101764
[TBL] [Abstract][Full Text] [Related]
33. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.
Hamdi Y; Soucy P; Kuchenbaeker KB; Pastinen T; Droit A; Lemaçon A; Adlard J; Aittomäki K; Andrulis IL; Arason A; Arnold N; Arun BK; Azzollini J; Bane A; Barjhoux L; Barrowdale D; Benitez J; Berthet P; Blok MJ; Bobolis K; Bonadona V; Bonanni B; Bradbury AR; Brewer C; Buecher B; Buys SS; Caligo MA; Chiquette J; Chung WK; Claes KB; Daly MB; Damiola F; Davidson R; De la Hoya M; De Leeneer K; Diez O; Ding YC; Dolcetti R; Domchek SM; Dorfling CM; Eccles D; Eeles R; Einbeigi Z; Ejlertsen B; ; Engel C; Gareth Evans D; Feliubadalo L; Foretova L; Fostira F; Foulkes WD; Fountzilas G; Friedman E; Frost D; Ganschow P; Ganz PA; Garber J; Gayther SA; ; Gerdes AM; Glendon G; Godwin AK; Goldgar DE; Greene MH; Gronwald J; Hahnen E; Hamann U; Hansen TV; Hart S; Hays JL; ; Hogervorst FB; Hulick PJ; Imyanitov EN; Isaacs C; Izatt L; Jakubowska A; James P; Janavicius R; Jensen UB; John EM; Joseph V; Just W; Kaczmarek K; Karlan BY; ; Kets CM; Kirk J; Kriege M; Laitman Y; Laurent M; Lazaro C; Leslie G; Lester J; Lesueur F; Liljegren A; Loman N; Loud JT; Manoukian S; Mariani M; Mazoyer S; McGuffog L; Meijers-Heijboer HE; Meindl A; Miller A; Montagna M; Mulligan AM; Nathanson KL; Neuhausen SL; Nevanlinna H; Nussbaum RL; Olah E; Olopade OI; Ong KR; Oosterwijk JC; Osorio A; Papi L; Park SK; Pedersen IS; Peissel B; Segura PP; Peterlongo P; Phelan CM; Radice P; Rantala J; Rappaport-Fuerhauser C; Rennert G; Richardson A; Robson M; Rodriguez GC; Rookus MA; Schmutzler RK; Sevenet N; Shah PD; Singer CF; Slavin TP; Snape K; Sokolowska J; Sønderstrup IM; Southey M; Spurdle AB; Stadler Z; Stoppa-Lyonnet D; Sukiennicki G; Sutter C; Tan Y; Tea MK; Teixeira MR; Teulé A; Teo SH; Terry MB; Thomassen M; Tihomirova L; Tischkowitz M; Tognazzo S; Toland AE; Tung N; van den Ouweland AM; van der Luijt RB; van Engelen K; van Rensburg EJ; Varon-Mateeva R; Wappenschmidt B; Wijnen JT; Rebbeck T; Chenevix-Trench G; Offit K; Couch FJ; Nord S; Easton DF; Antoniou AC; Simard J
Breast Cancer Res Treat; 2017 Jan; 161(1):117-134. PubMed ID: 27796716
[TBL] [Abstract][Full Text] [Related]
34. Replication of breast cancer susceptibility loci in whites and African Americans using a Bayesian approach.
O'Brien KM; Cole SR; Poole C; Bensen JT; Herring AH; Engel LS; Millikan RC
Am J Epidemiol; 2014 Feb; 179(3):382-94. PubMed ID: 24218030
[TBL] [Abstract][Full Text] [Related]
35. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
36. Mendelian randomization analyses of 23 known and suspected risk factors and biomarkers for breast cancer overall and by molecular subtypes.
Chen F; Wen W; Long J; Shu X; Yang Y; Shu XO; Zheng W
Int J Cancer; 2022 Aug; 151(3):372-380. PubMed ID: 35403707
[TBL] [Abstract][Full Text] [Related]
37. Associations of genetically predicted circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 with bladder cancer risk.
Tsai CW; Chang WS; Xu Y; Huang M; Bau DT; Gu J
Mol Carcinog; 2021 Nov; 60(11):726-733. PubMed ID: 34293213
[TBL] [Abstract][Full Text] [Related]
38. Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer.
Sun L; Ding H; Jia Y; Shi M; Guo D; Yang P; Wang Y; Liu F; Zhang Y; Zhu Z
Breast Cancer Res; 2022 Feb; 24(1):12. PubMed ID: 35151363
[TBL] [Abstract][Full Text] [Related]
39. [Circulating proteinic biomarkers and breast cancer].
Mathelin C; Koehl C; Rio MC
Gynecol Obstet Fertil; 2006; 34(7-8):638-46. PubMed ID: 16876456
[TBL] [Abstract][Full Text] [Related]
40. A pilot genome-wide association study of breast cancer susceptibility loci in Indonesia.
Haryono SJ; Datasena IG; Santosa WB; Mulyarahardja R; Sari K
Asian Pac J Cancer Prev; 2015; 16(6):2231-5. PubMed ID: 25824743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
